Organised by SHC
The 1st Asian Hepatology Summit Organised by SHC
Is NOW OPEN FOR REGISTRATION
SHC started out simply as the Singapore Hepatitis Conference in 2014. Over the last 12 years, it has grown to three (3) distinct yet related conferences covering different aspects of hepatology.
Thus we are renaming the entire event as the Asian Hepatology Summit organised by SHC. In 2025, the 1st Asian Hepatology Summit will cover 4 events: Singapore Hepatology Conference 2025, The Asian HBV/HDV Endpoints Consensus Meeting, Singapore MASLD Symposium and the GP Symposium.
In 2025, the Singapore Hepatology Conference will be holding its conference at the Sheraton Towers Hotel from 22 August to 24 August. SHC 2025 will include:
The Singapore Hepatology Conference which is focused on short, sharp and focused updates for the busy clinician covering all aspects of liver disease that are important for clinical practice.
The Science of HBV Cure Meeting which is focused on encouraging an exchange of ideas between scientists and clinicians from academia and pharmaceutical companies in their quest for a cure to Hepatitis B.
The Singapore MASLD Symposium (SMS) which focuses on the rapid advances in treating fatty liver disease or MASLD.
The GP Symposium is a half day symposium designed to update General Practitioner on relevant clinical practises for managing liver disease in primary care.
Friday 22 August to
Saturday 23 August 2025
For the Busy
Clinician:
Singapore Hepatology Conference 2025
A full two (2) day meeting focusing on short, sharp clinical updates for the busy clinician covering all aspects of Liver Disease that are important to clinical practice from the World’s leading experts
Friday 22 August to
Sunday 24 August 2025
For the Clinician, Public Health Specialist, Researcher, Scientist and Pharmaceutical Executive:
The Asian HBV/HDV Endpoints Consensus Meeting
This will be a three (3) day meeting focusing on establishing consensus as well as examining challenges and opportunities in Hepatitis B and Hepatitis D endpoints, from the clinical, scientific and public health perspectives in Asia. The Objectives are:
• Endpoints standardization and consensus-building.
• Novel treatments likely to achieve HBV Cure.
• Blood and liver biomarkers for HBV Cure.
Definitions and Treatments for HDV Cure
Sunday 24 August 2025
Programme @ a Glance
We will finalise the 1st Asian Hepatology Summit Programme over the course of the next few weeks. In the mean time, please check out our Programme @ a Glance and block out the dates to attend 1st Asian Hepatology Summit.
| Friday, 22 August 2025 | |
|---|---|
| Singapore Hepatology Conference 2025 | MASLD Session |
| Autoimmune Liver Diseases Session | |
| Advanced Liver Disease and Liver Failure Session | |
| Asian HBV/HDV Endpoints Consensus Meeting | Session 1 – Opening lecture: A need for Asian Consensus HBV Endpoint meeting – Overview of HBV virology and HBV immunology |
| Session 2 – Revisiting terminology for HBV endpoints for patients, functional cure, occult HBV infection, virological cure and complete cure |
|
| Session 3 – Novel biomarkers in clinical trials and clinical practice |
|
| Saturday, 23 August 2025 | |
|---|---|
| Singapore Hepatology Conference 2025 | HCC Session |
| Portal Hypertension Session | |
| Complex Case Discussions | |
| Asian HBV/HDV Endpoints Consensus Meeting | Session 4 – Existing treatment strategies including strategies for HBV cure |
| Session 5 – ALT flares |
|
| Session 6 – The role of evaluating the liver microenvironment in clinical trials of CHB |
|
| Sunday, 24 August 2025 | |
|---|---|
| Singapore MASLD Symposium | Advancing Care in MASLD |
| Asian HBV/HDV Endpoints Consensus Meeting | Session 7 – Delta Hepatitis – Delta Hepatitis endpoints |
| Session 8 – Delta Hepatitis existing therapy – Delta Hepatitis upcoming therapy |
|
| Consensus statement session | |
| GP Symposium | Managing liver disease in primary care |
Please click on the tabs for detailed programmes.
SHC organising the 1st Asian Hepatology Summit
Chairman’s Message
The Singapore Hepatology Conference began in 2013, and is now a well-recognised meeting all over Asia. However, the meeting no longer encompasses Singapore, but has become an Asia-wide meeting bringing together experts to provide short succinct summaries of new developments in liver disease necessary for practising clinicians, both generalists and specialists. We have expanded the meeting over the last 12 years, growing to three (3) distinct yet related meetings covering General Hepatology, MASLD and the Science of HBV Cure. In recognition of these developments we are renaming the Singapore Hepatology Conference, the Asian Hepatology Summit (AHS) organised by SHC.
In 2025, AHS will host
• A general hepatology meeting
• The Asian HBV/HDV Endpoints Consensus Meeting
• The Singapore MASLD Symposium and
• A General Practioner Symposium
For updates, please visit:
The 1st Asian Hepatology Summit will be held LIVE in Sheraton Tower Hotel, Singapore from Friday 22 August to Sunday 24 August 2025.
For those who would like to review the topics from SHC 2024 and before, please visit the website and login with your userID and password at e-Resources to access the Videos and Slides.
If you were not a registered attendee of the Conference in 2024, you will need to register on the SHC website as a user and pay a small fee of $20.00 to help us maintain the site.
Prof. Seng Gee Lim
Conference Chairman.
Asian Hepatology Summit by SHC
Some of the Experts You can Watch on Video
Coming Soon..
Click Call for Abstracts to access Abstract/Poster information and submission. Submission deadline Friday, 27 June 2025.
We invite you to submit CASE STUDIES for the Preceptorship Programme 2025.
Click Preceptorship Programme 2025 for Case Study templates and more information.
At SHC 2025, an international panel of world renowned thought leaders will provide updates on the latest strategies and treatment for liver diseases.